Vivos (RDGL) 10-Q 11 Aug 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Aug. 09, 2017
Document And Entity Information
Entity Registrant Name	ADVANCED MEDICAL ISOTOPE Corp
Entity Central Index Key	1,449,349
Document Type	10-Q
Document Period End Date	Jun. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		52,858,467
Trading Symbol	ADMD
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,017

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash	$ 369,449	$ 27,889
Prepaid expenses	6,823	11,990
Total current assets	376,272	39,879
Fixed assets, net of accumulated depreciation		1,473
Other assets:
Deposits	669	644
Total other assets	669	644
Total assets	376,941	41,996
Current liabilities:
Accounts payable and accrued expenses	860,189	1,137,086
Related party accounts payable	105,043	109,718
Accrued interest payable	311,829	114,755
Payroll liabilities payable	373,197	499,502
Convertible notes payable, net	1,477,099	544,508
Derivative liability	9	324,532
Related party promissory note	383,771	332,195
Total current liabilities	3,511,137	3,062,296
Total liabilities	3,511,137	3,062,296
Mezzanine Equity:
Preferred stock, $.001 par value, 20,000,000 shares authorized Series A preferred stock, $.001 par value, 5,000,000 shares authorized; 3,287,582 and 3,773,592 shares issued and outstanding, respectively	12,007,059	14,144,571
Total mezzanine equity	12,007,059	14,144,571
Stockholders' equity (deficit):
Common stock, $.001 par value; 2,000,000,000 shares authorized; 50,119,710 and 31,743,797 shares issued and outstanding, respectively	50,120	31,744
Paid in capital	44,613,625	40,672,825
Accumulated deficit	(59,805,000)	(57,869,440)
Total stockholders' equity (deficit)	(15,141,255)	(17,164,871)
Total liabilities and stockholders' equity (deficit)	$ 376,941	$ 41,996

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2017	Dec. 31, 2016
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	2,000,000,000	2,000,000,000
Common stock, issued	50,119,710	31,743,797
Common stock, outstanding	50,119,710	31,743,797
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	5,000,000	5,000,000
Preferred stock, issued	3,287,582	3,773,592
Preferred stock, outstanding	3,287,582	3,773,592

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Revenues		$ 4,054	$ 4,054	$ 8,108
Operating expenses
Sales and marketing expenses	15,251	135,708	41,249	147,544
Depreciation and amortization	733	737	1,473	1,475
Professional fees	295,544	1,631,616	430,148	1,702,585
Stock options granted	27,059	584,916	55,299	584,916
Payroll expenses	181,494	166,577	286,275	331,577
General and administrative expenses	99,090	703,350	173,496	1,141,392
Total operating expenses	619,171	3,222,904	987,940	3,909,489
Operating loss	(619,171)	(3,218,850)	(983,886)	(3,901,381)
Non-operating income (expense)
Interest expense	(781,139)	(400,524)	(1,309,090)	(449,733)
Net gain on sale of assets			2,800
Net gain (loss) on settlement of debt		(1,832,468)		(1,766,631)
Net gain (loss) on debt extinguishment	(201,574)		(53,863)
Gain (loss) on derivative liability	83,089	1,268,958	408,479	(3,871,040)
Non-operating income (expense), net	(899,624)	(964,034)	(951,674)	(6,087,404)
Income (Loss) before Income Taxes	(1,518,795)	(4,182,884)	(1,935,560)	(9,988,785)
Income Tax Provision
Net Income (Loss)	$ (1,518,795)	$ (4,182,884)	$ (1,935,560)	$ (9,988,785)
Basic and Diluted Income (Loss) per Common Share	$ (0.0327)	$ (0.0021)	$ (0.0457)	$ (0.0050)
Weighted average common shares outstanding	46,454,069	19,992,576	42,375,108	19,980,959

Condensed Statements of Cash Fl

Condensed Statements of Cash Flow (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
CASH FLOW FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ (1,935,560)	$ (9,988,785)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation of fixed assets	1,473	1,475
Amortization of licenses and intangible assets
Amortization of convertible debt discount	957,499	379,290
Gain on sale of assets	(2,800)
Preferred stock issued for loan fees		596,496
Common stock issued for services	171,090
Preferred stock for services		357,403
Preferred stock for wages		64,982
Stock options for services	55,299	584,916
Warrants issued for services		1,069,353
(Gain) loss on derivative liability	(408,479)	3,871,040
(Gain) loss on settlement of debt	53,863	1,766,631
Changes in operating assets and liabilities:
Prepaid expenses	5,142	(3,286)
Accounts payable	39,949	(292,802)
Related party accounts payable	(4,675)
Payroll liabilities	(60,212)	37,220
Accrued interest	350,468	70,443
Net cash used by operating activities	(776,944)	(1,485,624)
CASH FLOWS FROM INVESTING ACTIVITIES
Sale of fixed assets	2,800
Net cash from vesting activities	2,800
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments made for loan fees	(101,631)
Proceeds from shareholder advances	137,000
Proceeds from exercise of warrants		250
Payments on convertible debt		(10,000)
Proceeds from convertible debt	1,080,334	1,316,525
Net cash provided by financing activities	1,115,703	1,306,775
Net increase (decrease) in cash	341,560	(178,849)
Cash, beginning of period	27,889	179,032
CASH, END OF PERIOD	369,449	183
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies	NOTE 1: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES The accompanying condensed financial statements of Advanced Medical Isotope Corporation (the “ Company In April of 2017, the Company filed a Certificate of Merger with the Delaware Division of Corporations in order to merge the Company’s wholly-owned subsidiary, IsoPet Solutions Corporation, with and into the Company. The Company therefore no longer prepares Consolidated Financial Statements. Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that effect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2017 and December 31, 2016, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Financial Accounting Standards Board (“ FASB ASU Fair Value Measurements Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at June 30, 2017 and December 31, 2016: June 30, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 9 $ $ $ 9 Total Liabilities Measured at Fair Value $ 9 $ - $ - $ 9 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532 Recent Accounting Pronouncements There are no recently issued accounting pronouncements that the Company believes are applicable or would have a material impact on the financial statements of the Company.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2: GOING CONCERN The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company has suffered recurring losses and has used significant cash in support of its operating activities and the Company’s cash position is not sufficient to support the Company’s operations. Historically, the Company has relied upon outside investor funds to maintain the Company’s operations and develop the Company’s business. The Company anticipates it will continue to require funding from investors for working capital, as well as business expansion during this fiscal year and it can provide no assurance that additional investor funds will be available on acceptable terms. These factors, among others, indicate that there is substantial doubt regarding the Company’s ability to continue as a going concern within one year of the date these financial statements are issued. In addition, the Company’s ability to continue as a going concern must be considered in light of the problems, expenses and complications frequently encountered by entrance into established markets and the competitive environment in which it operates. The Company anticipates a requirement of $1.5 million in funds over the next twelve months to maintain current operating activities. The Company may also require up to approximately $4.6 million to retire outstanding debt and past due payables. As of June 30, 2017 the Company had convertible promissory notes in the aggregate principal amount of $3,254,130 outstanding (the “ Outstanding Notes Over the next 12 to 24 months, the Company believes it will cost approximately $5 million to $10 million to fund: (1) the Food and Drug Administration (“ FDA As of June 30, 2017, the Company has $369,449 cash on hand. There are currently commitments to vendors for products and services purchased, accrued compensation expenses and the Company’s current lease commitments that, in the absence of additional capital, would result in a liquidation of the Company. The current level of cash is not sufficient to cover the fixed and variable obligations of the Company. Assuming the Company is successful in the its sales/development effort, the Company believes that it will be able to raise additional funds through strategic agreements or the sale of the Company’s securities to either current stockholders or new investors. However, there is no guarantee that the Company will be able to raise additional funds or to do so at an advantageous price. The financial statements do not include any adjustments relating to the recoverability and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. The Company plans to seek additional funding to maintain its operations through debt and equity financing and to improve operating performance through a focus on strategic products and increased efficiencies in business processes and improvements to the cost structure. There is no assurance that the Company will be successful in its efforts to raise additional working capital or achieve profitable operations. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Fixed Assets

Fixed Assets	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Fixed Assets	NOTE 3: FIXED ASSETS Fixed assets consist of the following at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 Production equipment $ 15,182 $ 1,938,532 Office equipment - 32,769 15,182 1,971,301 Less accumulated depreciation (15,182 ) (1,969,828 ) $ - $ 1,473 Depreciation expense for the above fixed assets for the three months ended June 30, 2017 and 2016, respectively was $733 and $737 and for the six months ended June 30, 2017 and 2016, respectively, was $1,473 and $1,475.

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 4: INTANGIBLE ASSETS Intangible assets consist of the following at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 License Fee $ - $ 112,500 Less accumulated amortization - (112,500 ) Patents and intellectual property - - Intangible assets net of accumulated amortization $ - $ - The Company did not incur any amortization expense during the three and six months ended June 30, 2017 and 2016.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5: RELATED PARTY TRANSACTIONS Related Party Convertible Notes Payable In March 2017, the Company combined Outstanding Notes owed to a director and major stockholder, along with $51,576 of accrued interest payable, into one promissory note (the “ Related Party Note Rent Expenses The Company was renting office space from a significant shareholder and director of the Company on a month-to-month basis with a monthly payment of $1,500. This rental agreement was terminated as of April 1, 2017. Rental expense was $0 and $4,500 for each of the three months ended June 30, 2017 and 2016 and is recorded in general and administrative expense. Rental expense was $4,500 and $9,000 for the six months ending June 30, 2017 and 2016, respectively, and is recorded in general and administrative expense.

Convertible Notes Payable

Convertible Notes Payable	6 Months Ended
	Jun. 30, 2017
Convertible Notes Payable
Convertible Notes Payable	NOTE 6: CONVERTIBLE NOTES PAYABLE As of June 30, 2017 and December 31, 2016, the Company had the following convertible notes outstanding: June 30, 2017 December 31, 2016 Principal (net) Accrued Interest Principal (net) Accrued Interest July and August 2012 $1,060,000 Notes convertible into common stock at $4.60 per share, 12% interest, due December 2013 and January 2014 $ 45,000 $ 26,503 $ 95,000 50,365 May through October 2015 $605,000 Notes convertible into preferred stock at $1 per share, 8-10% interest, due September 30, 2015 - 17,341 - 17,341 October through December 2015 $613,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016, net of debt discount of $0 and $560,913, respectively - 5,953 - 5,953 January through March 2016 $345,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016 - 696 - 696 November 2016 $979,162 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $0 and $540,720, respectively - - 438,442 12,397 January and March 2017 $335,838 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $0 and $0, respectively - - - - May 2017 $2,378,155 Notes convertible into common stock after December 15, 2017 at a $0.20 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $1,321,989 and $0, respectively 1,056,166 178,304 - - May 2017 $694,539 Notes convertible into common stock after December 15, 2017 at a $0.12 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $383,140 and $0, respectively 311,399 56,319 - - May 2017 $130,312 Notes convertible after December 31, 2017 into common stock at a $0.13 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $71,901 and $0, respectively 58,411 15,773 - - Penalties on notes in default 6,123 - 11,066 - Total Convertible Notes Payable, Net $ 1,477,099 $ 300,889 $ 544,508 $ 86,752 During the six months ending June 30, 2017, the Company received proceeds from the issuance of 7.5% Original Issue Discount Senior Secured Convertible Debentures (“ Debentures The Company recorded $255,881 of conversions on certain Outstanding Notes and a total gain on settlement of $5,831 representing the write-off of Outstanding Note principal. Each of the Company’s Outstanding Notes have a conversion rate that is variable or has adjustment provisions. As a result of recording derivative liabilities at note inception, the Company increased the debt discount recorded on Outstanding Notes by $99,661 during the six months ending June 30, 2017. The Company also recorded amortization of $957,501 on Outstanding Note debt discounts. Lastly, the Company paid $101,631 in cash for loan fees and issued 743,699 shares of the Company’s Series A Convertible Preferred Stock (“ Series A Preferred

Common Stock Options and Warran

Common Stock Options and Warrants	6 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Common Stock Options and Warrants	NOTE 7: COMMON STOCK OPTIONS AND WARRANTS Common Stock Options The Company recognizes in the financial statements compensation related to all stock-based awards, including stock options and warrants, based on their estimated grant-date fair value. The Company has estimated expected forfeitures and is recognizing compensation expense only for those awards expected to vest. All compensation is recognized by the time the award vests. The following schedule summarizes the changes in the Company’s stock options: Weighted Weighted Options Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 2,402,500 $ 0.50-15 4.05 years $ - $ 0.81 Options granted - $ - - $ - Options exercised - $ - - $ - Options expired (180,000 ) $ 0.50-1.00 - $ 0.72 Balance at June 30, 2017 2,222,500 $ 0.50-15 3.67 years $ - $ 0.82 Exercisable at June 30, 2017 1,964,034 $ 0.50-15 3.63 years $ - $ 0.85 Common Stock Warrants The following schedule summarizes the changes in the Company’s stock warrants: Weighted Weighted Warrants Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 3,579,505 $ 0.10-10 0.52 years $ 749 $ 4.45 Warrants granted - $ - - $ - Warrants exercised - $ - - $ - Warrants expired/cancelled (3,196,818 ) $ 0.10-4.60 - $ 4.59 Balance at June 30, 2017 382,687 $ 0.10-10 1.37 years $ - $ 3.32 Exercisable at June 30, 2017 382,687 $ 0.10-10 1.37 years $ - $ 3.32

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Stockholders' Equity	NOTE 8: STOCKHOLDERS’ EQUITY Common Stock During the six months ending June 30, 2017, the Company issued 2,469,830 shares of its common stock valued at $281,657 for the settlement of debt, 1,596,483 shares of its common stock valued at $168,600 for accounts payable, 1,312,500 shares of its common stock valued at $171,089 for services, and 12,997,100 shares of its common stock valued at $3,282,531 for conversions of 1,239,710 shares of Series A Preferred. Preferred Stock During the six months ending June 30, 2017 the Company issued 743,699 shares of Series A Preferred valued at $1,116,110 as loan fees in connection with the issuance of the Debentures, and 10,000 shares of Series A Preferred valued at $28,908 for accrued payroll.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 30, 2017
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	NOTE 9: SUPPLEMENTAL CASH FLOW INFORMATION During the six months ending June 30, 2017, the Company had the following non-cash investing and financing activities: ● Increased convertible notes payable by $68,827, increased related party notes payable by $51,576, and decreased accrued interest by $120,403 for the reclassification of accrued interest to principal. ● Increased derivative liabilities for $99,661 to record a debt discount on convertible notes payable. ● Increased convertible notes payable and decreased loan from shareholder by $137,000 to roll proceeds from shareholder advances to a formal convertible note payable. ● Issued 743,699 shares of Series A Preferred for loan fees that increased the convertible note debt discount by $968,895. ● Issued 12,997,100 shares of common stock in exchange for 1,239,710 shares of Series A Preferred decreasing preferred stock by $3,282,530, increasing common stock by $12,997, and increasing paid in capital by $3,269,533. ● Issued 996,483 shares of common stock valued at $108,600 for the reduction of $205,283 of accounts payable, recording $96,683 as a gain on extinguishment of debt. ● Issued 600,000 shares of common stock valued at $60,000 and 10,000 shares of Series A Preferred A valued at $28,908 for the reduction of $66,093 of accrued payroll, recording $22,815 as a loss on extinguishment of debt. ● Issued 2,469,830 shares of common stock valued at $281,657 for the reduction of $255,881 of convertible notes payable and $32,991 of accrued interest, reducing debt discount by $197,062 and reducing derivative liability by $91,821, and recording $98,026 as a gain on extinguishment of debt. ● Issued 1,312,500 shares of common stock valued at $171,089 for services.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 10: COMMITMENTS AND CONTINGENCIES Effective June 21, 2017, the Company entered into a separation agreement with an individual previously associated with the Company, at times as a consultant and as an employee at other times. Pursuant to the agreement, the Company agreed to pay regular bi-weekly checks beginning July 7, 2017 and ending September 15, 2017, for a total of six checks in the aggregate amount of $28,846. The Company has accrued $28,846 for the payments to be made under this agreement and has recorded them in accounts payable as of June 30, 2017.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	NOTE 11: SUBSEQUENT EVENTS In July of 2017, the Company issued 370,000 shares of common stock upon conversion of 37,000 shares of Series A Preferred. In July of 2017, the Company issued 416,563 common stock shares in exchange for $46,500 of convertible debt principal and $3,488 of accrued interest. In July of 2017, the Company, in exchange for $206,072 of unpaid compensation, issued 1,500,000 common stock shares and 150,000 Series A Preferred and $10,000 cash plus $165,000 to be paid at the rate of 5% of the net proceeds retained by the Company in connection with all capital raises or net proceeds from revenue generated from licensing or similar transactions. The agreement also included the cancellation of 1,000.000 stock options issued June 21, 2016. In August 2017, the Company, in exchange for $27,198 of accounts payable, issued 302,194 common stock shares. In August 2017, the Company issued 150,000 common stock shares to consultants in exchange for services. The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no additional subsequent events to disclose.

Basis of Presentation and Sig17

Basis of Presentation and Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that effect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2017 and December 31, 2016, the balances reported for cash, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Financial Accounting Standards Board (“ FASB ASU Fair Value Measurements Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at June 30, 2017 and December 31, 2016: June 30, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 9 $ $ $ 9 Total Liabilities Measured at Fair Value $ 9 $ - $ - $ 9 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532
Recent Accounting Pronouncements	Recent Accounting Pronouncements There are no recently issued accounting pronouncements that the Company believes are applicable or would have a material impact on the financial statements of the Company.

Basis of Presentation and Sig18

Basis of Presentation and Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2017
Basis Of Presentation And Significant Accounting Policies Tables
Schedule of Fair Value of Financial Instruments	The Company measures certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis were calculated using the Black-Scholes pricing model and are as follows at June 30, 2017 and December 31, 2016: June 30, 2017 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 9 $ $ $ 9 Total Liabilities Measured at Fair Value $ 9 $ - $ - $ 9 December 31, 2016 Total Level 1 Level 2 Level 3 Liabilities: Derivative Liability $ 324,532 $ $ $ 324,532 Total Liabilities Measured at Fair Value $ 324,532 $ - $ - $ 324,532

Fixed Assets (Tables)

Fixed Assets (Tables)	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Fixed assets consist of the following at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 Production equipment $ 15,182 $ 1,938,532 Office equipment - 32,769 15,182 1,971,301 Less accumulated depreciation (15,182 ) (1,969,828 ) $ - $ 1,473

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following at June 30, 2017 and December 31, 2016: June 30, 2017 December 31, 2016 License Fee $ - $ 112,500 Less accumulated amortization - (112,500 ) Patents and intellectual property - - Intangible assets net of accumulated amortization $ - $ -

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Jun. 30, 2017
Convertible Notes Payable Tables
Schedule of Convertible Notes Payable	As of June 30, 2017 and December 31, 2016, the Company had the following convertible notes outstanding: June 30, 2017 December 31, 2016 Principal (net) Accrued Interest Principal (net) Accrued Interest July and August 2012 $1,060,000 Notes convertible into common stock at $4.60 per share, 12% interest, due December 2013 and January 2014 $ 45,000 $ 26,503 $ 95,000 50,365 May through October 2015 $605,000 Notes convertible into preferred stock at $1 per share, 8-10% interest, due September 30, 2015 - 17,341 - 17,341 October through December 2015 $613,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016, net of debt discount of $0 and $560,913, respectively - 5,953 - 5,953 January through March 2016 $345,000 Notes convertible into preferred stock at $1 per share, 8% interest, due June 30, 2016 - 696 - 696 November 2016 $979,162 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $0 and $540,720, respectively - - 438,442 12,397 January and March 2017 $335,838 Notes convertible into common stock at a variable conversion price, 10% interest, due May 2017, net of debt discounts of $0 and $0, respectively - - - - May 2017 $2,378,155 Notes convertible into common stock after December 15, 2017 at a $0.20 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $1,321,989 and $0, respectively 1,056,166 178,304 - - May 2017 $694,539 Notes convertible into common stock after December 15, 2017 at a $0.12 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $383,140 and $0, respectively 311,399 56,319 - - May 2017 $130,312 Notes convertible after December 31, 2017 into common stock at a $0.13 conversion price (subject to adjustment), 7.5% interest, due May 2018, net of debt discounts of $71,901 and $0, respectively 58,411 15,773 - - Penalties on notes in default 6,123 - 11,066 - Total Convertible Notes Payable, Net $ 1,477,099 $ 300,889 $ 544,508 $ 86,752

Common Stock Options and Warr22

Common Stock Options and Warrants (Tables)	6 Months Ended
	Jun. 30, 2017
Equity [Abstract]
Schedule Summarizes Changes in Stock Option	The following schedule summarizes the changes in the Company’s stock options: Weighted Weighted Options Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 2,402,500 $ 0.50-15 4.05 years $ - $ 0.81 Options granted - $ - - $ - Options exercised - $ - - $ - Options expired (180,000 ) $ 0.50-1.00 - $ 0.72 Balance at June 30, 2017 2,222,500 $ 0.50-15 3.67 years $ - $ 0.82 Exercisable at June 30, 2017 1,964,034 $ 0.50-15 3.63 years $ - $ 0.85
Schedule Summarizes Changes in Stock Warrants	The following schedule summarizes the changes in the Company’s stock warrants: Weighted Weighted Warrants Outstanding Average Average Number Exercise Remaining Aggregate Exercise Of Price Contractual Intrinsic Price Shares Per Share Life Value Per Share Balance at December 31, 2016 3,579,505 $ 0.10-10 0.52 years $ 749 $ 4.45 Warrants granted - $ - - $ - Warrants exercised - $ - - $ - Warrants expired/cancelled (3,196,818 ) $ 0.10-4.60 - $ 4.59 Balance at June 30, 2017 382,687 $ 0.10-10 1.37 years $ - $ 3.32 Exercisable at June 30, 2017 382,687 $ 0.10-10 1.37 years $ - $ 3.32

Basis of Presentation and Sig23

Basis of Presentation and Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Derivative Liability	$ 9	$ 324,532
Total Liabilities Measured at Fair Value	9	324,532
Level 1 [Member]
Derivative Liability
Total Liabilities Measured at Fair Value
Level 2 [Member]
Derivative Liability
Total Liabilities Measured at Fair Value
Level 3 [Member]
Derivative Liability	9	324,532
Total Liabilities Measured at Fair Value	$ 9	$ 324,532

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Current operation activities	$ 1,500,000
Retire outstanding debt	4,600,000
Convertible promissory notes principal amount	3,254,130
Convertible promissory notes	45,000
Cash on hand	369,449	$ 27,889
Minimum [Member]
Capital	5,000,000
Maximum [Member]
Capital	$ 10,000,000

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 733	$ 737	$ 1,473	$ 1,475

Fixed Assets - Schedule of Fixe

Fixed Assets - Schedule of Fixed Assets (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Total Fixed assets	$ 15,182	$ 1,971,301
Less accumulated depreciation	(15,182)	(1,969,828)
Net Fixed assets		1,473
Production Equipment [Member]
Total Fixed assets	15,182	1,938,532
Office Equipment [Member]
Total Fixed assets		$ 32,769

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Intangible Assets Details Narrative
Amortization expense of intangible assets

Intangible Assets - Schedule o

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
License Fee		$ 112,500
Less accumulated amortization		(112,500)
Patents and intellectual property
Intangible assets net of accumulated amortization

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2017	Dec. 31, 2016
Accrued interest payable	$ 300,889		$ 300,889			$ 86,752
Related party transaction accrued interest rate					10.00%
Related party promissory note	383,771		383,771			$ 332,195
Payment of rent			$ 1,500
Expire Date			Apr. 1, 2017
Rental expense	0	$ 4,500	$ 4,500	$ 9,000
Director [Member]
Accrued interest payable	$ 51,576		$ 51,576

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Proceeds from convertible note payable			$ 1,080,334	$ 1,316,525
Accrued interest payable	$ 300,889		300,889		$ 86,752
Debt original issue discounts	3,254,130		3,254,130
Payment of convertible note payable				10,000
Gain on settlement of debt	$ (201,574)		(53,863)
Amortization of debt			$ 957,499	$ 379,290
Number of shares issued			996,483
Series A Preferred Stock [Member]
Number of shares issued			12,997,100
Convertible Debentures [Member]
Original issue discount	7.50%		7.50%
Proceeds from convertible note payable			$ 1,080,334
Advances from shareholders	$ 137,000		137,000
Outstanding notes into debenture			1,358,750
Accrued interest payable	$ 120,403		$ 120,403
Accrued unpaid interest	$ 0.20		$ 0.20
Debt instrument due date			May 9, 2018
Debt original issue discounts	$ 757,696		$ 757,696
Loan fees			386,758
Outstanding Notes [Member]
Loan fees			101,631
Payment of convertible note payable			255,881
Gain on settlement of debt			5,831
Increase in debt discount			99,661
Amortization of debt			957,501
Outstanding Notes [Member] | Series A Preferred Stock [Member]
Increase in debt discount			$ 1,116,110
Number of shares issued			743,699

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Principal (net)	$ 1,477,099	$ 544,508
Accrued Interest	300,889	86,752
Penalties on notes past due principal (net)	6,123	11,066
Penalties on notes in default accrued interest
Convertible Notes Payable One [Member]
Principal (net)	45,000	95,000
Accrued Interest	26,503	50,365
Convertible Notes Payable Two [Member]
Principal (net)
Accrued Interest	17,341	17,341
Convertible Notes Payable Three [Member]
Principal (net)
Accrued Interest	5,953	5,953
Convertible Notes Payable Four [Member]
Principal (net)
Accrued Interest	696	696
Convertible Notes Payable Five [Member]
Principal (net)		438,442
Accrued Interest		12,397
Convertible Notes Payable Six [Member]
Principal (net)
Accrued Interest
Convertible Notes Payable Seven [Member]
Principal (net)	1,056,166
Accrued Interest	178,304
Convertible Notes Payable Eight [Member]
Principal (net)	311,399
Accrued Interest	56,319
Convertible Notes Payable Nine [Member]
Principal (net)	58,411
Accrued Interest	$ 15,773

Convertible Notes Payable - S32

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) (Parenthetical) - USD ($)	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Debt principal amount	$ 3,254,130
Convertible Notes Payable One [Member]
Debt principal amount	$ 1,060,000
Debt conversion price per share	$ 4.60
Debt interest rate	12.00%
Debt maturity date description	December 2013 and January 2014
Convertible Notes Payable Two [Member]
Debt principal amount	$ 605,000
Debt conversion price per share	$ 1
Debt maturity date description	September 30, 2015
Convertible Notes Payable Two [Member] | Minimum [Member]
Debt interest rate	8.00%
Convertible Notes Payable Two [Member] | Maximum [Member]
Debt interest rate	10.00%
Convertible Notes Payable Three [Member]
Debt principal amount	$ 613,000
Debt conversion price per share	$ 1
Debt interest rate	8.00%
Debt maturity date description	June 30, 2016
Debt discount	$ 0	$ 560,913
Convertible Notes Payable Four [Member]
Debt principal amount	$ 345,000
Debt conversion price per share	$ 1
Debt interest rate	8.00%
Debt maturity date description	June 30, 2016
Convertible Notes Payable Five [Member]
Debt principal amount	$ 979,162
Debt interest rate	10.00%
Debt maturity date description	May 2,017
Debt discount	$ 0	540,720
Convertible Notes Payable Six [Member]
Debt principal amount	$ 335,838
Debt interest rate	10.00%
Debt maturity date description	May 2,017
Debt discount	$ 0	0
Convertible Notes Payable Seven [Member]
Debt principal amount	$ 2,378,155
Debt conversion price per share	$ 0.20
Debt interest rate	7.50%
Debt maturity date description	May 2,018
Debt discount	$ 1,321,989	0
Convertible Notes Payable Eight [Member]
Debt principal amount	$ 694,539
Debt conversion price per share	$ 0.12
Debt interest rate	7.50%
Debt maturity date description	May 2,018
Debt discount	$ 383,140	0
Convertible Notes Payable Nine [Member]
Debt principal amount	$ 130,312
Debt conversion price per share	$ 0.13
Debt interest rate	7.50%
Debt maturity date description	May 2,018
Debt discount	$ 71,901	$ 0

Common Stock Options and Warr33

Common Stock Options and Warrants - Schedule Summarizes Changes in Stock Option (Details) - Stock Options	6 Months Ended
	Jun. 30, 2017USD ($)$ / sharesshares
Number of Shares Options Outstanding Beginning Balance | shares	2,402,500
Number of Options Granted | shares
Number of Options Exercised | shares
Number of Options Expired | shares	(180,000)
Number of Shares Options Outstanding Ending Balance | shares	2,222,500
Number of Shares Options Exercisable | shares	1,964,034
Weighted Average Remaining Contractual Life (in years) Outstanding, Beginning	4 years 18 days
Weighted Average Remaining Contractual Life (in years) Outstanding, Ending	3 years 8 months 2 days
Weighted Average Remaining Contractual Life (in years) Exercisable	3 years 7 months 17 days
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Exercisable | $
Weighted Average Exercise Price Per Share Outstanding Beginning	$ 0.81
Weighted Average Exercise Price Per Share Options Granted
Weighted Average Exercise Price Per Share Options Exercised
Weighted Average Exercise Price Per Share Options Expired	0.72
Weighted Average Exercise Price Per Share Outstanding Ending	0.82
Weighted Average Exercise Price Per Share Exercisable	0.85
Minimum [Member]
Weighted Average Exercise Price Outstanding Beginning Balance	0.50
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Expired	0.50
Weighted Average Exercise Price Outstanding Ending Balance	0.50
Exercise Price Per Share Exercisable	0.50
Maximum [Member]
Weighted Average Exercise Price Outstanding Beginning Balance	15
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Expired	1
Weighted Average Exercise Price Outstanding Ending Balance	15
Exercise Price Per Share Exercisable	$ 15

Common Stock Options and Warr34

Common Stock Options and Warrants - Schedule Summarizes Changes in Stock Warrants (Details) - Warrants [Member]	6 Months Ended
	Jun. 30, 2017USD ($)$ / sharesshares
Number of Shares, Warrants Outstanding Beginning | shares	3,579,505
Number of Shares, Warrants Granted | shares
Number of Shares, Warrants Exercised | shares
Number of Shares, Warrants expired/cancelled | shares	(3,196,818)
Number of Shares, Warrants Outstanding Ending | shares	382,687
Number of Shares, Warrants Exercisable Ending | shares	382,687
Weighted Average Remaining Contractual Life (in years) Warrants Outstanding, Beginning	6 months 7 days
Weighted Average Remaining Contractual Life (in years) Warrants Outstanding Ending	1 year 4 months 13 days
Weighted Average Remaining Contractual Life (in years) Warrants Exercisable	1 year 4 months 13 days
Aggregate Intrinsic Value Outstanding | $	$ 749
Aggregate Intrinsic Value Outstanding | $
Aggregate Intrinsic Value Exercisable | $
Weighted Average Exercise Price Per Share Exercise Price Warrants Beginning	$ 4.45
Weighted Average Exercise Price Per Share Exercise Price Warrants Granted
Weighted Average Exercise Price Per Share Exercise Price Warrants Exercised
Weighted Average Exercise Price Per Share Exercise Price Warrants Expired/cancelled	4.59
Weighted Average Exercise Price Per Share Exercise Price Warrants Ending	3.32
Weighted Average Exercise Price Per Share Exercise Price Warrants Exercisable	3.32
Minimum [Member]
Weighted Average Exercise Price Outstanding	0.10
Exercise Price Per Share Warrants Granted
Exercise Price Per Share Warrants Exercised
Exercise Price Per Share Warrants Expired/cancelled	0.10
Weighted Average Exercise Price Outstanding	0.10
Exercise Price Per Share Exercisable	0.10
Maximum [Member]
Weighted Average Exercise Price Outstanding	10
Exercise Price Per Share Warrants Granted
Exercise Price Per Share Warrants Exercised
Exercise Price Per Share Warrants Expired/cancelled	4.60
Weighted Average Exercise Price Outstanding	10
Exercise Price Per Share Exercisable	$ 10

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Number of shares issued	996,483
Number of shares issued, value	$ 108,600
Common stock issued for services, value	$ (171,090)
Common Stock [Member]
Number of shares issued	2,469,830
Number of shares issued, value	$ 281,657
Common stock issued for services	1,312,500
Common stock issued for services, value	$ 171,089
Series A Preferred Stock [Member]
Number of shares issued	12,997,100
Number of shares issued, value	$ 3,282,531
Common stock issued for debt conversions, shares	1,239,710
Settlement of Debt [Member]
Number of shares issued	2,469,830
Number of shares issued, value	$ 281,657
Accounts Payable [Member]
Number of shares issued	1,596,483
Number of shares issued, value	$ 168,600
Debentures [Member] | Series A Preferred Stock [Member]
Number of shares issued	743,699
Number of shares issued, value	$ 1,116,110
Issuance of shares during period	10,000
Accrued payroll	$ 28,908

Supplemental Cash Flow Inform36

Supplemental Cash Flow Information (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Increase in convertible note payable	$ 68,827
Increase in related party debt	51,576
Decrease in accrued interest	120,403
Increase decrease in derivative liabilities	99,661
Increased convertible notes payable and decreased loan from shareholder	$ 137,000
Number of preferred stock shares issued for loan fees on convertible promissory notes	743,699
Number of preferred stock issued for loan fees on convertible promissory notes	$ 968,895
Number of shares issued	996,483
Number of shares issued, value	$ 108,600
Reduction amount	205,283
Gain loss on extinguishment of debt	93,683
Accrued interest	311,829		$ 114,755
Stock issued during services	$ (171,090)
Series A Preferred Stock [Member]
Number of shares issued	12,997,100
Issued shares of common stock in exchange for preferred stock	1,239,710
Decrease in preferred stock	$ 3,282,530
Increase in common stock	12,997
Increase in additional paid in capital	3,269,533
Number of shares issued, value	3,282,531
Gain loss on extinguishment of debt	$ 22,815
Number of shares issued for reduction of accrued payroll and loss on extinguishment of debt,shares	10,000
Number of shares issued for reduction of accrued payroll and loss on extinguishment of debt	$ 28,908
Accrued payroll	66,093
Common Stock [Member]
Increase decrease in derivative liabilities	$ 91,821
Number of shares issued	2,469,830
Number of shares issued, value	$ 281,657
Reduction amount	255,881
Gain loss on extinguishment of debt	$ 98,026
Number of shares issued for reduction of accrued payroll and loss on extinguishment of debt,shares	600,000
Number of shares issued for reduction of accrued payroll and loss on extinguishment of debt	$ 60,000
Accrued interest	32,991
Reduction in debt discount	$ 197,062
Stock issued during services, shares	1,312,500
Stock issued during services	$ 171,089

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	6 Months Ended
	Jun. 30, 2017USD ($)
Accrued payable	$ 28,846
Consultant [Member]
Aggregated amount	28,846
Employee [Member]
Aggregated amount	$ 28,846

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Aug. 31, 2017	Jul. 31, 2017	Jun. 21, 2016	Jun. 30, 2017
Debt principal amount				$ 3,254,130
Common Stock [Member]
Stock issued during services, shares				1,312,500
Subsequent Event [Member]
Number of shares issued up on conversion		416,563
Debt conversion of convertible debt		$ 46,500
Debt principal amount		3,488
Unpaid compensation		$ 206,072
Debt interest rate		5.00%
Cancellation of stock option issued			1,000,000
Subsequent Event [Member] | Common Stock [Member]
Number of shares issued up on conversion	302,194	370,000
Unpaid compensation, shares		1,500,000
Stock based compensation		$ 10,000
Accounts payable	$ 27,198
Subsequent Event [Member] | Common Stock [Member] | Consultant [Member]
Stock issued during services, shares	150,000
Subsequent Event [Member] | Series A Preferred Stock [Member]
Number of shares issued up on conversion		37,000
Unpaid compensation, shares		150,000
Stock based compensation		$ 165,000